Markets:

Overview

News

Currencies

International

Treasuries

Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

0.2251 +0.0051 (+2.32%)

Streaming Delayed Price Updated: 12:23 PM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Outlook Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

MarketBeat Week in Review – 6/17 - 6/21

June 22, 2024

Markets were calmer this week, with the Dow index posting the biggest gains, but it's too early to tell if this is the start of a broader market rally

Via MarketBeat

Topics Economy Stocks

Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside

June 19, 2024

Outlook Therapeutics (NASDAQ: OTLK) has gained attention, with analysts forecasting an upside of over 500% based on the consensus price target.

Via MarketBeat

OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024 ↗

May 15, 2024

OTLK stock results show that Outlook Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential ↗

April 15, 2024

With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.

Via InvestorPlace

Insiders Buying Outlook Therapeutics And 2 Other Stocks ↗

April 01, 2024

Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades.

Via Benzinga

Gold Moves Lower; Lululemon Shares Plummet ↗

March 22, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 0.3% on Friday. The Dow traded down 0.49% to 39,585.67 while the NASDAQ rose 0.26% to 16,444.91. The S&P 500...

Via Benzinga

Topics Stocks

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 22, 2024

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 22, 2024

Via Benzinga

Dow Dips 200 Points; Nike Shares Fall After Q3 Results ↗

March 22, 2024

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points. The Dow traded down 0.54% to 39,565.50 while the NASDAQ rose 0.04% to 16,408.74. The S&P 500 also...

Via Benzinga

Topics Stocks

Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday? ↗

March 22, 2024

Outlook Therapeutics stock sees uptick as European Medicines Agency committee issues positive opinion on ONS-5010/LYTENAVA for wet age-related macular degeneration (wet AMD). Strong trading volume...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 22, 2024

Via Benzinga

Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

March 12, 2024

The Dow Jones index closed higher by around 47 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

7 of the Best Speculative Stocks You Can Snag for Less Than $1 ↗

March 06, 2024

Although speculative stocks under $1 are by their very nature extremely risky, these ideas might have enough to go the distance.

Via InvestorPlace

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory ↗

February 25, 2024

Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 23, 2024

Via Benzinga

OTLK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK

January 01, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

OTLK DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action – OTLK

January 01, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

OTLK IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK

December 31, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

OTLK DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK

December 31, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

OTLK DEADLINE ALERT: ROSEN, A LEADING AND RANKED FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK

December 30, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

OUTLOOK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. and Encourages Investors to Contact the Firm

December 29, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

OTLK DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK

December 29, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday ↗

December 29, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

OTLK DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action - OTLK

December 28, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outlook Therapeutics, Inc. (OTLK)

December 28, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

OTLK Stock Earnings: Outlook Therapeutics Reported Results for Q4 2023 ↗

December 27, 2023

Outlook Therapeutics just reported results for the fourth quarter of 2023.

Via InvestorPlace

OUTLOOK SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Outlook To Contact Him Directly To Discuss Their Options

December 27, 2023

From Faruqi & Faruqi LLP

Via GlobeNewswire

OUTLOOK THERAPEUTICS, INC. (NASDAQ: OTLK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Outlook Therapeutics, Inc.

December 27, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.